Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Molecular Biology of the Cell|September 21, 2007
Atf1 is a target of the mitogen-activated protein kinase Pmk1 and regulates cell integrity in fission yeastHirofumi Takada, Masayuki Nishimura, Yuta Asayama, et al.
Plos One|July 7, 2022
Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patientsKumiko Shirai, Hayato Hikita, Sadatsugu Sakane, et al.
Hepatology Communications|September 29, 2021
Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse LiverMakiko Urabe, Hayato Hikita, Yoshinobu Saito, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 7, 2017
Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohortAkira Doi, Ryotaro Sakamori, Yuki Tahata, et al.
Scientific Reports|February 10, 2021
Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regenerationYasutoshi Nozaki, Hayato Hikita, Satoshi Tanaka, et al.
Biomarker Research|March 4, 2025
Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinomaYuto Shiode, Takahiro Kodama, Yu Sato, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 13, 2022
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinomaKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Scientific Reports|September 18, 2020
Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activationYuto Shiode, Hayato Hikita, Satoshi Tanaka, et al.
Journal of Gastroenterology|January 27, 2019
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver miceAkira Doi, Hayato Hikita, Yugo Kai, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|September 13, 2020
Efficacy and safety of cold forceps biopsy for diminutive pharyngeal neoplasms: Single-center, prospective pilot studyYuichi Shimodate, Junya Itakura, Tomohiko Sunami, et al.
Pageof 7